CONTINUOUS, NORMAL HUMAN TLYMPHOCYTE CELL LINES COMPRISING A RECOMBINANT IMMUNE RECEPTOR WITH DEFINED ANTIGEN SPECIFICITY

Details for Australian Patent Application No. 2002237217 (hide)

Owner CELLCURE APS

Inventors KALTOFT, Keld

Pub. Number AU-A-2002237217

PCT Pub. Number WO2002/072796

Priority PA 2001 00415 12.03.01 DK; 60/274,643 12.03.01 US

Filing date 12 March 2002

Wipo publication date 24 September 2002

International Classifications

C12N 005/00 Undifferentiated human, animal or plant cells, e.g. cell lines

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002237217

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002237218-CHASSIS WITH GROUND SPIKES FOR DECOMPACTING SOIL AND CONTROLLING METHOD THEREFOR

2002237216-SCREENING METHOD COMPRISING COMBINATION OF DISCRETE DIMENSION ASSAY TESTING OF ACTIVES, GENE MUTATION AND APPLICATION ASSAY TESTING OF SELECTED ACTIVES